Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chevron Co. stock logo
CVX
Chevron
$162.01
+1.3%
$155.63
$139.62
$172.38
$297.16B1.127.02 million shs6.78 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$149.12
+0.8%
$155.97
$143.13
$175.97
$356.43B0.537.30 million shs10.11 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$26.26
+1.0%
$27.08
$25.23
$40.37
$147.23B0.6134.71 million shs35.67 million shs
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chevron Co. stock logo
CVX
Chevron
+1.26%+2.80%+4.75%+14.02%-4.20%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.82%+1.11%-3.94%-6.66%-8.34%
Pfizer Inc. stock logo
PFE
Pfizer
+1.00%+1.39%-4.02%-7.63%-34.69%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Chevron Co. stock logo
CVX
Chevron
4.8929 of 5 stars
3.43.05.00.03.22.53.1
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.8896 of 5 stars
3.23.04.23.93.02.51.9
Pfizer Inc. stock logo
PFE
Pfizer
4.9909 of 5 stars
3.25.04.24.82.01.73.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Chevron Co. stock logo
CVX
Chevron
2.74
Moderate Buy$184.7514.04% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.46
Hold$175.8617.93% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.38
Hold$36.3338.36% Upside

Current Analyst Ratings

Latest PFE, JNJ, and CVX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Chevron Co. stock logo
CVX
Chevron
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$180.00 ➝ $204.00
4/18/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$169.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$168.00 ➝ $167.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$180.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$181.00 ➝ $175.00
4/15/2024
Chevron Co. stock logo
CVX
Chevron
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$170.00 ➝ $174.00
4/15/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
4/15/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
4/11/2024
Chevron Co. stock logo
CVX
Chevron
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Perform ➝ Sector Outperform$170.00 ➝ $195.00
4/10/2024
Chevron Co. stock logo
CVX
Chevron
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$203.00
4/9/2024
Chevron Co. stock logo
CVX
Chevron
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$185.00 ➝ $197.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Chevron Co. stock logo
CVX
Chevron
$200.95B1.50$22.53 per share7.19$85.78 per share1.89
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.16B4.22$13.78 per share10.82$28.57 per share5.22
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.54$3.00 per share8.74$15.81 per share1.66

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Chevron Co. stock logo
CVX
Chevron
$21.37B$11.3614.2610.352.3610.63%15.24%9.56%4/26/2024 (Confirmed)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$16.049.3013.622.4445.26%36.43%15.01%7/18/2024 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B$0.3672.949.481.173.62%10.88%4.91%5/1/2024 (Confirmed)

Latest PFE, JNJ, and CVX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
Pfizer Inc. stock logo
PFE
Pfizer
$0.57N/A-$0.57N/AN/AN/A  
4/26/2024N/A
Chevron Co. stock logo
CVX
Chevron
$3.06N/A-$3.06N/AN/AN/A  
4/16/2024Q1 24
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.64$2.71+$0.07$3.22$21.39 billion$21.38 billion    
2/2/202412/31/2023
Chevron Co. stock logo
CVX
Chevron
$3.19$3.45+$0.26$5.68$50.93 billion$47.18 billion    
1/30/202412/31/2023
Pfizer Inc. stock logo
PFE
Pfizer
-$0.19$0.10+$0.29$0.80$14.37 billion$14.25 billion    
1/23/202412/31/2023
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.28$2.29+$0.01$2.91$21.02 billion$21.40 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Chevron Co. stock logo
CVX
Chevron
$6.524.02%+5.39%57.39%37 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.763.19%+5.70%29.68%63 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.686.40%+2.57%466.67%15 Years

Latest PFE, JNJ, and CVX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.36%5/20/20245/21/20246/4/2024
2/2/2024
Chevron Co. stock logo
CVX
Chevron
Quarterly$1.634.28%2/15/20242/16/20243/11/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Chevron Co. stock logo
CVX
Chevron
0.13
1.27
1.01
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.38
1.16
0.91
Pfizer Inc. stock logo
PFE
Pfizer
0.69
0.91
0.69

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Chevron Co. stock logo
CVX
Chevron
72.42%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Chevron Co. stock logo
CVX
Chevron
0.18%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Chevron Co. stock logo
CVX
Chevron
45,6001.86 billion1.85 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
131,9002.41 billion2.41 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.66 billion5.66 billionOptionable

PFE, JNJ, and CVX Headlines

SourceHeadline
Pfizer vs Moderna battle over COVID vaccine patents begins in UKPfizer vs Moderna battle over COVID vaccine patents begins in UK
finance.yahoo.com - April 23 at 7:37 AM
Pfizer vs Moderna battle over COVID vaccine patents begins in UKPfizer vs Moderna battle over COVID vaccine patents begins in UK
reuters.com - April 23 at 7:21 AM
New York State Common Retirement Fund Has $281.24 Million Position in Pfizer Inc. (NYSE:PFE)New York State Common Retirement Fund Has $281.24 Million Position in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 22 at 9:33 PM
Pfizer (PFE) Rises Higher Than Market: Key FactsPfizer (PFE) Rises Higher Than Market: Key Facts
zacks.com - April 22 at 6:51 PM
3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years
investorplace.com - April 22 at 5:44 PM
EC approval for Pfizer’s Emblaveo in multidrug-resistant infectionsEC approval for Pfizer’s Emblaveo in multidrug-resistant infections
thepharmaletter.com - April 22 at 3:24 PM
Pfizers Emblaveo Gets EU Marketing Authorization For Serious Infectious DiseasePfizer's Emblaveo Gets EU Marketing Authorization For Serious Infectious Disease
markets.businessinsider.com - April 22 at 3:24 PM
EU regulators approve Pfizer antibiotic EmblaveoEU regulators approve Pfizer antibiotic Emblaveo
seekingalpha.com - April 22 at 3:24 PM
Pfizer (NYSE:PFE) Stock Price Up 1.1%Pfizer (NYSE:PFE) Stock Price Up 1.1%
marketbeat.com - April 22 at 1:55 PM
European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment OptionsEuropean Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
finance.yahoo.com - April 22 at 8:35 AM
European Commission Approves Pfizers EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment OptionsEuropean Commission Approves Pfizer's EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
businesswire.com - April 22 at 8:08 AM
Brendel Financial Advisors LLC Buys New Position in Pfizer Inc. (NYSE:PFE)Brendel Financial Advisors LLC Buys New Position in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 21 at 6:22 PM
Pfizer (NYSE:PFE) Trading 0.9% Higher Pfizer (NYSE:PFE) Trading 0.9% Higher
americanbankingnews.com - April 21 at 3:56 AM
abrdn plc Grows Stake in Pfizer Inc. (NYSE:PFE)abrdn plc Grows Stake in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 20 at 12:11 PM
3 Stocks Under $50 You Can Buy Hand Over Fist Right Now3 Stocks Under $50 You Can Buy Hand Over Fist Right Now
fool.com - April 20 at 5:50 AM
Palouse Capital Management Inc. Grows Position in Pfizer Inc. (NYSE:PFE)Palouse Capital Management Inc. Grows Position in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 19 at 9:47 PM
Pfizer Stock (NYSE:PFE), Analyst Ratings, Price Targets, PredictionsPfizer Stock (NYSE:PFE), Analyst Ratings, Price Targets, Predictions
benzinga.com - April 19 at 7:53 PM
ProSource360 wins opportunity to partner with Pfizer through its Diverse OnDemand MarketplaceProSource360 wins opportunity to partner with Pfizer through its Diverse OnDemand Marketplace
finance.yahoo.com - April 19 at 2:53 PM
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending StockHere is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
zacks.com - April 19 at 10:05 AM
6 Left For Dead Blue Chip Dividend Stocks Could Rally Big This Summer6 Left For Dead Blue Chip Dividend Stocks Could Rally Big This Summer
247wallst.com - April 19 at 9:41 AM
6 Left For Dead Blue Chip Dividend Stocks Could Rally Big This Summer6 Left For Dead Blue Chip Dividend Stocks Could Rally Big This Summer
247wallst.com - April 19 at 9:41 AM
Unveiling Pfizers Potent Cocktail: Key Drivers Of Free Cash Flow GrowthUnveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth
seekingalpha.com - April 19 at 7:03 AM
Pfizer (NYSE:PFE) Hits New 1-Year Low at $25.26Pfizer (NYSE:PFE) Hits New 1-Year Low at $25.26
marketbeat.com - April 18 at 4:55 PM
Xponance Inc. Grows Position in Pfizer Inc. (NYSE:PFE)Xponance Inc. Grows Position in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 18 at 4:41 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Chevron logo

Chevron

NYSE:CVX
Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant. The Downstream segment refines crude oil into petroleum products; markets crude oil, refined products, and lubricants; manufactures and markets renewable fuels, commodity petrochemicals, plastics for industrial uses, and fuel and lubricant additives; and transports crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car. The company was formerly known as ChevronTexaco Corporation and changed its name to Chevron Corporation in 2005. Chevron Corporation was founded in 1879 and is headquartered in San Ramon, California.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.